Magnentum

Magnentum, Inc. is a Joint Venture of ADI Group and Ken Robinson in the domain of Clinical Trial Regulatory Services. Driven by the innovation, passion and experience of industry experts, Magnentum offers the pharmaceutical industry expert solutions for drug development needs – from study design through the final submission. Magnentum has extensive experience and is well acquainted with multiple approaches to documenting clinical trials in over 100 regulatory submissions including NDAs, MAAs, marketing applications in Asia, background packages, and a full range of other clinical documents required at various stages for regulatory submissions.